BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 21183891)

  • 1. Current role and future perspective of MRI for diagnosis and characterization of renal cell carcinoma.
    Schoth F; Persigehl T; Palmowski M
    Panminerva Med; 2010 Dec; 52(4):307-18. PubMed ID: 21183891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance imaging of the kidneys and adrenal glands.
    Baumgartner BR; Chezmar JL
    Semin Ultrasound CT MR; 1989 Feb; 10(1):43-62. PubMed ID: 2697325
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renal cell carcinoma: presentation, staging, and surgical treatment.
    Russo P
    Semin Oncol; 2000 Apr; 27(2):160-76. PubMed ID: 10768595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Characterization and staging of renal tumors: significance of MRI diagnostics].
    Kalinka A; Gerlach A; Arlart IP; Günes N; Hauser TK; Würstlin S; Bosse A
    Rofo; 2006 Mar; 178(3):298-305. PubMed ID: 16508837
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Imaging of renal cell carcinoma.
    Hilton S
    Semin Oncol; 2000 Apr; 27(2):150-9. PubMed ID: 10768594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dynamic contrast-enhanced magnetic resonance imaging for assessing tumor vascularity and vascular effects of targeted therapies in renal cell carcinoma.
    Rosen MA; Schnall MD
    Clin Cancer Res; 2007 Jan; 13(2 Pt 2):770s-776s. PubMed ID: 17255308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal cell carcinoma 2005: new frontiers in staging, prognostication and targeted molecular therapy.
    Lam JS; Shvarts O; Leppert JT; Figlin RA; Belldegrun AS
    J Urol; 2005 Jun; 173(6):1853-62. PubMed ID: 15879764
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal cell carcinoma invading the urinary collecting system: implications for staging.
    Uzzo RG; Cherullo E; Myles J; Novick AC
    J Urol; 2002 Jun; 167(6):2392-6. PubMed ID: 11992044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging in renal cell carcinoma.
    Krajewski KM; Giardino AA; Zukotynski K; Van den Abbeele AD; Pedrosa I
    Hematol Oncol Clin North Am; 2011 Aug; 25(4):687-715. PubMed ID: 21763963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measuring perfusion and permeability in renal cell carcinoma with dynamic contrast-enhanced MRI: a pilot study.
    Notohamiprodjo M; Sourbron S; Staehler M; Michaely HJ; Attenberger UI; Schmidt GP; Boehm H; Horng A; Glaser C; Stief C; Reiser MF; Herrmann KA
    J Magn Reson Imaging; 2010 Feb; 31(2):490-501. PubMed ID: 20099364
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Renal masses: urologic management.
    Ornstein DK; Arcangeli CG; Andriole GL
    Magn Reson Imaging Clin N Am; 1997 Feb; 5(1):1-12. PubMed ID: 8995121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [The importance of magnetic resonance tomography in the diagnosis and staging of renal cell carcinoma].
    Krestin GP; Gross-Fengels W; Marincek B
    Radiologe; 1992 Mar; 32(3):121-6. PubMed ID: 1565792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Advances in the staging of renal cell carcinoma with high-resolution imaging].
    Hallscheidt P; Noeldge G; Schawo S; Bartling S; Kauffmann G; Pfitzenmaier J; Palmowski M
    Rofo; 2007 Dec; 179(12):1236-42. PubMed ID: 18004691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The staging of renal-cell carcinomas in MRT and CT--a prospective histologically controlled study].
    Hallscheidt P; Stolte E; Roeren T; Pomer S; Drehmer I; Kauffmann GW
    Rofo; 1998 Feb; 168(2):165-70. PubMed ID: 9519049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging as a biomarker in renal cell carcinoma.
    Pedrosa I; Alsop DC; Rofsky NM
    Cancer; 2009 May; 115(10 Suppl):2334-45. PubMed ID: 19402070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal vein ostium wall invasion of renal cell carcinoma with an inferior vena cava tumor thrombus: prediction by renal and vena caval vein diameters and prognostic significance.
    Zini L; Destrieux-Garnier L; Leroy X; Villers A; Haulon S; Lemaitre L; Koussa M
    J Urol; 2008 Feb; 179(2):450-4; discussion 454. PubMed ID: 18076946
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of dynamic contrast-enhanced and diffusion weighted magnetic resonance imaging in the female pelvis.
    Sala E; Rockall A; Rangarajan D; Kubik-Huch RA
    Eur J Radiol; 2010 Dec; 76(3):367-85. PubMed ID: 20810230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictive value of magnetic resonance imaging and computerized tomography for conservative renal surgery in an ex vivo tumor enucleation study followed by step-sectioning.
    Gschwend JE; Vogel U; Bader C; Mattfeldt T; Hautmann RE
    J Urol; 1996 Feb; 155(2):451-4. PubMed ID: 8558633
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic significance of perinephric fat infiltration and tumor size in renal cell carcinoma.
    Yoo C; Song C; Hong JH; Kim CS; Ahn H
    J Urol; 2008 Aug; 180(2):486-91; discussion 491. PubMed ID: 18550101
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Percutaneous radiofrequency ablation with transarterial embolization is useful for treatment of stage 1 renal cell carcinoma with surgical risk: results at 2-year mean follow up.
    Arima K; Yamakado K; Kinbara H; Nakatsuka A; Takeda K; Sugimura Y
    Int J Urol; 2007 Jul; 14(7):585-90; discussion 590. PubMed ID: 17645597
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.